March 2014 | Oncology & Biotech News

Aduro BioTech Immunotherapy Duo Shows Promise in Pancreatic Cancer

April 03, 2014

The use of immunotherapy for pancreatic cancer has had limited exposure, but Aduro BioTech, Inc, has had phase II success with an approach in which two vaccines are administered. The vaccines, GVAX Pancreas and CRS-207, are administered to patients sequentially.

Filling a Gap in Posttransplant Care: The Transitional Transplant Clinic

March 28, 2014

The Long-Term Follow-Up (LTFU) Clinical Program at Seattle Cancer Care Alliance (SCCA) has expanded its scope of services to assist in the hands-on management of patients who develop complex conditions more than 100 days after their peripheral blood hematopoietic stem cell transplant procedure